Thrombotic diseases, in particular cardiovascular and cerebrovascular thrombotic diseases, have become the top cause of death in the population of China, and their incidence has increased, seriously endangering human health.

China has been engaged in the R&D and manufacturing of semi-automatic coagulation analyzers for over a decade, and based on the data from the website of the NMPA, in 2024 and 2025 (as od 15 August), a total of 2 instruments from 2 manufacturers have obtained registration certificates...

The Wyss Institute and Harvard University said on Tuesday that they have licensed protein detection technology to Spear Bio.

Merck, known as MSD outside the United States and Canada, today announced that the U.S. FDA has granted Fast Track designation for Merck’s investigational anticoagulant therapy MK-2060 for the reduction in risk of major thrombotic cardiovascular events in patients with end-stage renal disease.

Recently, the monkeypox virus nucleic acid detection kit (PCR-fluorescent probe method) independently developed by Sansure Biotech has passed the British MHRA certification. This is another authoritative certification obtained after the EU CE.

Pillar Biosciences said Monday that China's National Medical Products Administration has granted commercial approval for its OncoReveal Dx Colon Cancer Assay.

The Biden administration has been planning for how to get past the crisis phase of the Covid-19 pandemic and will stop buying vaccines, treatments and tests as early as this fall, White House Covid-19 Response Coordinator Dr. Ashish Jha said on Tuesday.

According to reports, Shanghai United Imaging Healthcare Co., Ltd was officially listed on the SSE STAR Market on August 22 with the stock code "688271".

Investigators at the University of Miami Miller School of Medicine, the University of Iowa turned to a multiomics approach to untangle the downstream consequences of RB1 tumor suppressor inactivation in retinoblastoma, a common and dangerous eye cancer that can occur in children.

Researchers at the University of California, Los Angeles have identified noncoding genetic regulatory elements that impact the risk of dementia from Alzheimer's disease and the pathologically related progressive supranuclear palsy (PSP).

As an important medical resource to save lives, blood safety is very important and blood screening is the most critical link to ensure blood safety.

A pair of new studies examines genetic variations that confer risk of developing autism spectrum disorder, providing insight into the different phenotypes associated with the disorder.